Ark Genomic (1ARKG) | Financial Analysis & Statements
Ark Genomic Revolution Trust Micro-cap
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
No financial overview data available.
Ark Genomic Income Statement
No income statement data available.
Ark Genomic Balance Sheet
No balance sheet data available.
Ark Genomic Cash Flow Statement
No cash flow data available.
Ark Genomic Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
0.39
Price to Book
0.03
Price to Sales
0.00
Profitability Ratios
Profit Margin
64.71%
Operating Margin
0.00%
Return on Equity
-209.77%
Return on Assets
9.79%
Financial Health
Current Ratio
1.20
Debt to Equity
1.39
Per Share Data
EPS (TTM)
€5.22
Book Value per Share
€10.93
Revenue per Share
€25.90
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| 1ARKG | 0 | 0.39 | 0.03 | -209.77% | 64.71% | 1.39 |
| iShares Bitcoin ETP | 0 | - | - | 0.00% | 0.00% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.